ReNeuron Group plc Profit Margin

The latest profit margin for RNUGF is -1231.01% as of September 2023. That compares with -6884.57% in the prior-year period — up 82.1% year over year. That is below the Healthcare sector average of 9.71%. Investors often review this figure alongside ReNeuron Group plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, RNUGF's profit margin moved from -6884.57% to -1231.01% — a 82.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ReNeuron Group plc's valuation or profitability profile.

Against Healthcare companies, RNUGF currently prints -1231.01% for profit margin, while the sector average sits near 9.71%. That is roughly 12783.0% below the sector mean. Large gaps often invite a closer look at ReNeuron Group plc's growth, margins, and balance sheet.

Profit Margin shows how effectively ReNeuron Group plc converts resources into returns. At -1231.01%, RNUGF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6884.57% in the prior-year period — up 82.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RNUGF's profit margin (-1231.01%), review year-over-year change from -6884.57%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.